Clincosm LogoSign in Get a demo

Epidemiology of Merkel Carcinomas in the Bas-Rhin

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT03518307
Collaborator
(none)
150
Enrollment
1
Location
12
Anticipated Duration (Months)
12.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this work is to study demographic, clinical, management (diagnostic and therapeutic) and survival data concerning patients with Merkel's carcinoma in the Lower Rhine, thus obtaining the first French data.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    150 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Epidemiology of Merkel Carcinomas in the Bas-Rhin From 1983 to 2011: General Population Study Based on the Bas-Rhin Cancer Registry
    Actual Study Start Date :
    Sep 1, 2017
    Anticipated Primary Completion Date :
    Sep 1, 2018
    Anticipated Study Completion Date :
    Sep 1, 2018

    Outcome Measures

    Primary Outcome Measures

    1. Retrospective study of demographic, clinical, management (diagnostic and therapeutic) and survival data for patients with Merkel carcinoma in the Lower Rhine region [The period from from January 1st, 1983 to December 31st, 2011 will be examined]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • Age >18 years

    • Diagnosis of primary Merkel carcinoma (topographic code C44 morphological code 8247/3)

    • Diagnosis made between 1983 and 2011

    • Patient residing in the Bas-Rhin at the date of diagnosis

    • Patient who has given his consent for the use of his data for research purposes

    Exclusion Criteria:
    • Refusal to participate in research

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service de Dermatologie Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    • Principal Investigator: Dan LIPSKER, MD, PhD, University Hospital, Strasbourg, France

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT03518307
    Other Study ID Numbers:
    • 6840
    First Posted:
    May 8, 2018
    Last Update Posted:
    May 8, 2018
    Last Verified:
    Apr 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Merkel carcinoma
    Additional relevant MeSH terms:
    Carcinoma

    Study Results

    No Results Posted as of May 8, 2018